Omega Fund Management as of Sept. 30, 2024
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 11 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bicara Therapeutics Common Stock (BCAX) | 35.1 | $56M | 2.2M | 25.47 | |
| Nuvation Bio Common Stock Class A (NUVB) | 18.7 | $30M | 13M | 2.29 | |
| Replimune Group Common Stock (REPL) | 16.9 | $27M | 2.5M | 10.96 | |
| Lexeo Therapeutics Common Stock (LXEO) | 13.3 | $21M | 2.4M | 9.04 | |
| enGene Holdings Common Stock (ENGN) | 4.4 | $7.1M | 1.1M | 6.60 | |
| Alumis Common Stock (ALMS) | 4.4 | $7.0M | 653k | 10.68 | |
| Ikena Oncology Common Stock (IKNA) | 2.4 | $3.9M | 2.2M | 1.73 | |
| Sana Biotechnology Common Stock (SANA) | 2.2 | $3.5M | 844k | 4.16 | |
| Immunic Common Stock (IMUX) | 1.8 | $3.0M | 1.8M | 1.65 | |
| enGene Holdings Warrant (ENGNW) | 0.4 | $675k | 322k | 2.10 | |
| Syros Pharmaceuticals Common Stock (SYRS) | 0.3 | $540k | 251k | 2.15 |
